arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

RETRACTABLE TECHNOLOGIES INC

RVP
$0.69 ▲ +0.01 (+1.71%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
18 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
29
Health
Poor
Moderately Bearish
auto_awesome

Analytical Summary

RETRACTABLE TECHNOLOGIES INC faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). On the positive side, Debt to Equity remains strong. Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $20.7M
Dividend Yield —
Revenue Growth 15.8% ↗
Op. Margin -55.3% ↗
ROIC -28.8% ↗
FCF / Share $-0.24 ↗
Trailing P/E —
Price / Book 0.3x
FCF Yield —
Debt / Equity 0.01
info Valuation on last close. End-of-day price, Sep 23, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$38.27M
↑ +15.8% —
Net Income Profit after all expenses
$-12.57M
↓ -5.7% —
Operating Margin Operating profit as % of sales
-55.3%
↑ +13.3% 5th
FCF / Share Free cash flow per share
$-0.24
↑ +45.6% —
Long-Term Debt Long-term obligations
$895.64K
↓ -27.3% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
7
Returns
29
Financial Health ↓
51
Cash Quality
43

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 18 years · 68 quarters